Potassium Chloride Tablet, Extended Release
Product Images NDC 64380-861

These are extended-release, potassium chloride tablets containing 600mg of Potassium Chloride USP per tablet. The dosage must be adjusted according to the patient's individual needs, and the tablets should be stored at a controlled room temperature and protected from light and moisture. The packaging should have a child-resistant closure for safety purposes. These tablets are manufactured and distributed by Strides Pharma Inc. However, be aware that the expended matrix is not absorbed and may be excreted in the stool.*

This text is a description of a medicine called Potassium Chloride Extended-Release Tablets, USP. Each tablet contains 750 mg of Potassium Chloride USP. The dosage must be adjusted to the individual needs of each patient. It is essential to keep the medicine in a tight container with a child-resistant closure, at room temperature, and protect it from light and moisture. The text cautions that the expended matrix is not absorbed and may be excreted intact in the stool. The medicine contains FD&C Yellow No. 5 (tartrazine) as a color additive, and the FDA approved acceptance criteria for assay differs from USP test. The manufacturer details such as NDC, company name, and address along with a code number along with revised and LOT and EXP details are also provided.*